Use of chlorogenic acid in preparation of drug for preventing and treating ocular inflammation
US12364677B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2017 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Dec 2, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chlorogenic acid is used in the preparation of a drug for treating and/or preventing ocular inflammation. Chlorogenic acid can significantly alleviate symptoms of uveitis and scleritis, and has good treatment effects on ocular inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.